Results 121 to 130 of about 4,695 (214)

Severe maternal morbidity in pregnancies complicated by maternal seizure disorder

open access: yesPregnancy, Volume 2, Issue 6, November 2026.
Abstract Introduction Seizure disorders are a common comorbidity of pregnancy, leading to increased maternal and neonatal complications. In particular, we sought to identify the impact of seizure disorders on severe maternal morbidity (SMM) and hypertensive disorders of pregnancy in a contemporary cohort.
Janki Amin   +4 more
wiley   +1 more source

Low‐lying placenta is associated with increased risk of hemorrhage and severe maternal morbidity: A nationwide analysis

open access: yesPregnancy, Volume 2, Issue 6, November 2026.
Abstract Background Placenta previa (PP) is a well‐recognized obstetric complication with established maternal risks, particularly hemorrhage, that contribute significantly to maternal morbidity. In contrast, low‐lying placenta (LLP) has historically been grouped with previa in both coding and clinical practice, limiting our ability to study its ...
May Abiad   +8 more
wiley   +1 more source

Hemolytic anemia and heart failure caused by anti-C and anti-E immunization

open access: yes, 2016
Many different blood group systems, such as Rh, ABO, Kell, Kidd, Duffy, MNS, have been reported as causes of hemolytic disease of the newborn. Hemolysis due to minor blood group incompatibility in the fetus or newborn has been determined in isolated case
Eren, Abdülkadir   +2 more
core   +2 more sources

Categorizing differences in postpartum hemorrhage management and associated clinical factors

open access: yesPregnancy, Volume 2, Issue 6, November 2026.
Abstract Objective To examine whether there is variation in postpartum hemorrhage (PPH) management and whether differences are associated with patient‐level factors and delivery hospital. Methods This is a retrospective cohort study of patients delivered at ≥20 weeks of gestation at any of four hospitals within one Connecticut healthcare system, with ...
Moeun Son   +8 more
wiley   +1 more source

Hemolytic Disease of Fetus and Newborn: A 24-Year Nationwide Cohort Study on Incidence, Management, and Outcomes

open access: yesClinical and Experimental Obstetrics & Gynecology
Background: Hemolytic disease of the fetus and newborn (HDFN) can cause severe prenatal and postnatal outcomes. The main objective of this study is to characterize the clinical impact of HDFN on pregnant women and their newborns.
Noga Fallach   +11 more
doaj   +1 more source

Sickle cell anaemia with and without crises: An observational study of pregnancy outcomes

open access: yesBritish Journal of Haematology, Volume 209, Issue 5, Page 2264-2272, November 2026.
Summary We assessed the pregnancy outcomes of patients with sickle cell crises. We carried out a retrospective study of 2 698 556 pregnancies in Quebec, Canada between 1989 and 2022. The primary exposure was sickle cell anaemia with crisis during or outside of pregnancy. Outcomes included severe maternal morbidity and other pregnancy complications.
Nathalie Auger   +8 more
wiley   +1 more source

Alloimmunization to low and high prevalence blood group antigens: rare causes of hemolytic disease of the fetus and newborn.

open access: yes
Maternal alloimmunization to paternal blood group antigens is the underlying cause of hemolytic disease of the fetus and newborn. Alloantibodies to the major, clinically significant blood group antigens are readily identified by the blood bank which, in ...
Blackall, Douglas P, Tomlinson, Mark W
core   +1 more source

Bronchopulmonary Dysplasia Starts in Utero: MicroRNA Dysregulation Across the Fetal–Neonatal Continuum in the Bronchopulmonary Dysplasia Development

open access: yesJournal of Cellular and Molecular Medicine, Volume 30, Issue 21, November 2026.
ABSTRACT Bronchopulmonary dysplasia (BPD) is a heterogeneous developmental lung disorder resulting from the interaction between antenatal susceptibility and postnatal injury. Increasing evidence suggests that its biological origins may precede preterm birth, with placental dysfunction, fetal growth restriction, inflammation and oxidative stress ...
Serafina Perrone   +13 more
wiley   +1 more source

Monitoring and management of hemolytic disease of the fetus and newborn based on an international expert Delphi Consensus

open access: yes
The study aimed to develop structured, expert-based clinical guidance on the prenatal and postnatal management of hemolytic disease of the fetus and newborn.
Sambatur, Enaja V   +4 more
core   +1 more source

Fucosylation limits ADCC in clinically used anti‐RhD monoclonal antibodies

open access: yesTransfusion, Volume 66, Issue 11, Page 2360-2372, November 2026.
Abstract Background Haemolytic disease of the fetus and newborn (HDFN) is caused by maternal alloantibodies, often targeting the D antigen on fetal red blood cells. Maternal immunization is preventable with timely administration of anti‐D polyclonal antibodies (pAbs).
Gabriela Koike   +33 more
wiley   +1 more source

Home - About - Disclaimer - Privacy